Expertise in
1
conditions

Donald W. Morrish

Edmonton, AB, CA 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
1
conditions
Edmonton, AB, CA 

Overview

Donald Morrish practices practicing medicine in Edmonton, Canada.

Mr. Morrish is highly rated in 1 condition, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Osteoporosis, Sialadenitis, and Thyroidectomy.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Edmonton, AB T6G1Z2, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: August 08, 2025
Intervention Type: Drug
Study Drug: [177]Lu-DOTA-TATE
Study Phase: Phase 2
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: [68]Ga-HA-DOTATATE
Study Phase: Phase 1/Phase 2

9 Total Publications

Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms.
Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms.
Journal: Journal of endocrinological investigation
Published: March 15, 2022

Frequently Asked Questions about Donald W. Morrish

Is Donald W. Morrish a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Donald W. Morrish is classified as an Advanced expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Donald W. Morrish participate in research or clinical trials?

Yes. Donald W. Morrish has published 9 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Donald W. Morrish's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Morrish's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile